Skip to main navigation Skip to search Skip to main content

Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: A Children's Oncology Group report

  • S. Goldman
  • , L. Smith
  • , J. R. Anderson
  • , S. Perkins
  • , L. Harrison
  • , M. B. Geyer
  • , T. G. Gross
  • , H. Weinstein
  • , S. Bergeron
  • , B. Shiramizu
  • , W. Sanger
  • , M. Barth
  • , J. Zhi
  • , M. S. Cairo

Research output: Contribution to journalLetterpeer-review

147 Scopus citations
Original languageEnglish
Pages (from-to)1174-1177
Number of pages4
JournalLeukemia
Volume27
Issue number5
DOIs
StatePublished - May 2013

Fingerprint

Dive into the research topics of 'Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: A Children's Oncology Group report'. Together they form a unique fingerprint.

Cite this